111 related articles for article (PubMed ID: 38660840)
1. [The Regulatory Effect of RNA m
Li YQ; Shao YL; Li MY; Wang LL; Gao XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):382-388. PubMed ID: 38660840
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
[TBL] [Abstract][Full Text] [Related]
3. HIF1α-mediated transactivation of WTAP promotes AML cell proliferation via m
Shao YL; Li YQ; Li MY; Wang LL; Zhou HS; Liu DH; Yu L; Lin J; Gao XN
Leukemia; 2023 Jun; 37(6):1254-1267. PubMed ID: 37087529
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
[TBL] [Abstract][Full Text] [Related]
5. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
6. [The Relationship between HIF1α and WTAP Expression Level in t(8;21) Acute Myeloid Leukemia].
Shao YL; Chen Z; Wang LL; Liu DH; Gao XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1424-1428. PubMed ID: 34627420
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
8. Histone H3K9 demethylase JMJD2B/KDM4B promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells by regulating H3K9me2 on RUNX2.
Kang P; Wu Z; Huang Y; Luo Z; Huo S; Chen Q
PeerJ; 2022; 10():e13862. PubMed ID: 36217382
[TBL] [Abstract][Full Text] [Related]
9. [Effects of
Li Y; Shi LH; Xie X; Fan PK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1599-1607. PubMed ID: 38071034
[TBL] [Abstract][Full Text] [Related]
10. The m
Guo S; Zhao C; Fang L; Xu W; Dalia S; Glass J; Shikama N; Zhang Z
Ann Transl Med; 2022 Jul; 10(14):779. PubMed ID: 35965785
[TBL] [Abstract][Full Text] [Related]
11. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
Zhang L; Su X
Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
[TBL] [Abstract][Full Text] [Related]
12. Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML.
Liu M; Yu B; Tian Y; Li F
BMC Cancer; 2024 Jan; 24(1):98. PubMed ID: 38233760
[TBL] [Abstract][Full Text] [Related]
13. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
14. Chidamide inhibits t(8;21) AML cell proliferation and AMK1/ETO and C-KIT expression by inhibiting ERK1/2 signaling pathway.
Liu J; Lv N; Zhou L; Li Y; Yu L
Transl Cancer Res; 2020 Feb; 9(2):827-839. PubMed ID: 35117428
[TBL] [Abstract][Full Text] [Related]
15. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
[TBL] [Abstract][Full Text] [Related]
16. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
17. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
[TBL] [Abstract][Full Text] [Related]
19. KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility.
Ueda T; Kanai A; Komuro A; Amano H; Ota K; Honda M; Kawazu M; Okada H
FASEB Bioadv; 2021 Dec; 3(12):1020-1033. PubMed ID: 34938963
[TBL] [Abstract][Full Text] [Related]
20. Effects of demethylase KDM4B on the biological characteristics and function of yak cumulus cells in vitro.
Xiong X; Ma H; Min X; Su F; Xiong Y; Li J
Theriogenology; 2021 Oct; 174():85-93. PubMed ID: 34425304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]